Alpha-1-antitrypsin deficiency (A1ATD) is a monogenic inherited liver disease with 180,000 individua...
Blog Posts
Learn more about our company, iPSC platform, drug discovery technologies, and exemplars of our disease models
Have you ever wondered how DefiniGEN’s proprietary OptiDIFF technology gives them a competitive adva...
What is the FDA Modernization Act 2.0?
The Babraham Research Campus is located on the outskirts of Cambridge, England on the site of the hi...
Introducing iPSCs DefiniGEN's technology platform enables the generation of predictive and phenotypi...